T0	Outcomes 41 98	fibrinolysis, inflammation, and blood product transfusion
T1	Outcomes 232 325	release of nitric oxide, inflammatory cytokines, and tissue-type plasminogen activator (t-PA)
T2	Outcomes 438 603	fibrinolytic and inflammatory response to CPB and that bradykinin B2 receptor antagonism reduces fibrinolysis, inflammation, and subsequent transfusion requirements.
T3	Outcomes 776 822	decreased intraoperative fibrinolytic capacity
T4	Outcomes 854 881	decreased D-dimer formation
T5	Outcomes 896 927	decrease postoperative bleeding
T6	Outcomes 955 1008	decreased fibrinolysis and EACA attenuated blood loss
T7	Outcomes 1139 1157	to t-PA generation
T8	Outcomes 1214 1235	on plasmin generation
T9	Outcomes 1247 1282	to decreased D-dimer concentrations